Russia’s NHL stars Radulov, Zaitsev summoned to national squad for 2017 IIHF ChampionshipSport April 24, 13:50
Lavrov notes anti-Russia sanctions brought up during talks with MogheriniRussian Politics & Diplomacy April 24, 13:46
Armenia remembers 1915 genocide victimsWorld April 24, 13:28
Russia’s seaborne air defense system to receive three types of missilesMilitary & Defense April 24, 13:09
Press review: Le Pen-Macron duel and Western-style populism in RussiaPress Review April 24, 13:00
Attorney says no attempts from Trump administration to contact SnowdenWorld April 24, 12:59
Re-enactment of WWII Battle of Berlin staged in MoscowSociety & Culture April 24, 12:37
Testing of Russian air defense system Vityaz to be completed by 2017Military & Defense April 24, 12:31
Moscow interested in restoring ties with EURussian Politics & Diplomacy April 24, 11:51
MOSCOW, May 27. /TASS/. Doping test result of Russian heavyweight boxer Alexander Povetkin, who Sample B tested positive for banned substance meldonium, was not unexpected news and his team was ready for it, Andrei Ryabinsky, the head of the Boxing World promotion company told TASS on Friday.
"It was expected," Ryabinsky said in an interview with TASS. "We never denied that it [meldonium] was there [in Povetkin’s blood]."
WBC Heavyweight Champion Deontay Wilder of the United States (W36-L0, 35 KOs) was scheduled to hold his mandatory title bout against Povetkin (30-1, 22 KOs) on May 21 in Moscow, However, Russian boxer’s doping Sample A had tested positive for meldonium shortly before the fight and the bout was suspended indefinitely.
"This story is about the low concentration of detected meldonium," Ryabinsky said. "However, nobody ever denied that it was present in the [doping] samples."
The found drug in the body system of the 36-year-old Russian fighter was in low concentration of 0.07 micrograms. US sports channel ESPN later reported that before the positive doping result, Povetkin passed doping tests three times, namely on April, 7,8 and 11, and all his samples tested negative. However, his doping test as of April 27 gave a positive indication for meldonium presence in his blood.
Wilder’s management announced earlier it intended to demand from the Russian side a financial compensation of $4.6 million in case the bout was eventually cancelled.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
However, on April 13, WADA announced that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.